ELIPFHE: The Effect of Labor on Intraocular Pressure Fluctuation in Healthy Eyes

Sponsor
Faculty Hospital Kralovske Vinohrady (Other)
Overall Status
Recruiting
CT.gov ID
NCT06016712
Collaborator
(none)
9
1
1
4.8
1.9

Study Details

Study Description

Brief Summary

Glaucoma is a multifactorial disease, an important risk factor of which is increased intraocular pressure. Fluctuations in intraocular pressure are often associated with vaginal birth, although intraocular pressure during active pushing during stage II has never been measured.. The study will be conducted on a group of patients with healthy eyes on patients who have completely fine vision or have a small refractive error and are accustomed to wearing contact lenses. The measurement of intraocular pressure itself will be carried out using SENSIMED Triggerfish contact lenses, which measure pressure every 5 minutes for 30s. This period roughly corresponds to the duration of 1-2 contractions. Inclusion in the study will be offered to patients in the 35th to 37th week of pregnancy. Prior to measurement patients will be sent to an eye clinic for a detailed examination of both eyes, which includes measuring intraocular pressure. Subsequently, pregnancy checks will take place according to the standard scheme and in the standard scope. At the onset of uterine contractions, an ophthalmologic consultant will be called, which will measure intraocular pressure between contractions using the Tonopen device and put on SENSIMED Trigerfish contact lenses in combination with a local anesthetic. The patient will have these lenses until the end of the third stage of labor, i.e. 2 hours after the birth, when the lenses are removed. In the second stage of labor, continuous monitoring by a cardiotocograph will take place. Subsequently, the obtained data from the cardiotocograph and contact lenses will be evaluated and compared by a team of ophthalmologists and gynecologists, where the investigators will be able to assess the individual fluctuations in intraocular pressure depending on the individual contractions. The aim of the study is to demonstrate or disprove the risks to the glaucoma patient due to increased intraocular pressure during active pushing in combination with uterine contraction.

Condition or Disease Intervention/Treatment Phase
  • Device: SENSIMED Triggerfish Eye Lenses
N/A

Detailed Description

Glaucoma is a multifactorial disease, an important risk factor of which is increased intraocular pressure. Fluctuations in intraocular pressure are often associated with vaginal birth, although intraocular pressure during active pushing during stage II has never been measured. The study will be conducted on a group of patients with healthy eyes on patients who have completely fine vision or have a small refractive error and are accustomed to wearing contact lenses. The measurement of intraocular pressure itself will be carried out using SENSIMED Triggerfish contact lenses, which measure pressure every 5 minutes for 30s. This period roughly corresponds to the duration of 1-2 contractions. Inclusion in the study will be offered to patients in the 35th to 37th week of pregnancy.Prior to measurement patients will be sent to an eye clinic for a detailed examination of both eyes, which includes measuring intraocular pressure. Subsequently, pregnancy checks will take place according to the standard scheme and in the standard scope. At the onset of uterine contractions, an ophthalmologic consultant will be called, which will measure intraocular pressure between contractions using the Tonopen device and put on SENSIMED Trigerfish contact lenses in combination with a local anesthetic. The patient will have these lenses until the end of the third stage of labor, i.e. 2 hours after the birth, when the lenses are removed. In the second stage of labor, continuous monitoring by a cardiotocograph will take place. Subsequently, the obtained data from the cardiotocograph and contact lenses will be evaluated and compared by a team of ophthalmologists and gynecologists, where the investigators will be able to assess the individual fluctuations in intraocular pressure depending on the individual contractions. The aim of the study is to demonstrate or disprove the risks to the glaucoma patient due to increased intraocular pressure during active pushing in combination with uterine contraction.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
9 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Masking Description:
No masking
Primary Purpose:
Treatment
Official Title:
The Effect of Labor on Intraocular Pressure Fluctuation in Healthy Eyes
Actual Study Start Date :
Aug 8, 2023
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Participant

SENSIMED Triggerfish lenses will be applied on this Arm and Intraocular pressure during active phase of delivery will be measured

Device: SENSIMED Triggerfish Eye Lenses
Contact lenses used for measuring intraocular pressure.

Outcome Measures

Primary Outcome Measures

  1. Intraocular pressure [From start of regular contractions for the length of 24 hours (at least 2 hours after delivery if patient complies about the lenses)]

    Investigators will use SENSIMED Triggerfish Lenses - contact lenses used for measuring intraocular pressure. Lenses are sending detailed description of intraocular pressure in regular time range. Measurements are then send to the software which compares all collected data.

  2. Uterine contractions [Continuous CTG will be done during II phase of delivery and at least every 2 hours durins I phase of delivery]

    Cardiotocography will be used for measuring regular uterine activity. Tocography will be used for evaluation of uterine activity compared to intraocular pressure

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • physiological pregnancy

  • primiparous women

Exclusion Criteria:
  • multiparous women

  • pathological pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty Hospital Kralovske Vinohrady Praha Czechia 11000

Sponsors and Collaborators

  • Faculty Hospital Kralovske Vinohrady

Investigators

  • Study Chair: Pavel Studeny, prof, MD, Ph.D., Fakultni Nemocnice Kralovske Vinohrady

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jan Zapletal, Medical Doctor, Department of Obstetrics and Gynecology, Faculty Hospital Kralovske Vinohrady
ClinicalTrials.gov Identifier:
NCT06016712
Other Study ID Numbers:
  • EK-VP/55l012022
  • Internal hospital grant
First Posted:
Aug 30, 2023
Last Update Posted:
Aug 30, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jan Zapletal, Medical Doctor, Department of Obstetrics and Gynecology, Faculty Hospital Kralovske Vinohrady

Study Results

No Results Posted as of Aug 30, 2023